• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Soluble ST2 Is Associated With New Epileptiform Abnormalities Following Nontraumatic Subarachnoid Hemorrhage.可溶性 ST2 与非创伤性蛛网膜下腔出血后新的癫痫样异常有关。
Stroke. 2020 Apr;51(4):1128-1134. doi: 10.1161/STROKEAHA.119.028515. Epub 2020 Mar 11.
2
Electroencephalography, Hospital Complications, and Longitudinal Outcomes After Subarachnoid Hemorrhage.脑电图、医院并发症和蛛网膜下腔出血后的纵向结局。
Neurocrit Care. 2021 Oct;35(2):397-408. doi: 10.1007/s12028-020-01177-x. Epub 2021 Jan 22.
3
Soluble ST2 links inflammation to outcome after subarachnoid hemorrhage.可溶性 ST2 与蛛网膜下腔出血后结局相关。
Ann Neurol. 2019 Sep;86(3):384-394. doi: 10.1002/ana.25545. Epub 2019 Jul 30.
4
Association of Soluble ST2 With Functional Outcome, Perihematomal Edema, and Immune Response After Intraparenchymal Hemorrhage.可溶性 ST2 与脑内出血后功能结局、血肿周围水肿和免疫反应的关系。
Neurology. 2023 Mar 28;100(13):e1329-e1338. doi: 10.1212/WNL.0000000000206764. Epub 2022 Dec 22.
5
Early Circulating Lactate and Glucose Levels After Aneurysmal Subarachnoid Hemorrhage Correlate With Poor Outcome and Delayed Cerebral Ischemia: A Two-Center Cohort Study.动脉瘤性蛛网膜下腔出血后早期循环乳酸和葡萄糖水平与不良预后及迟发性脑缺血相关:一项双中心队列研究。
Crit Care Med. 2016 May;44(5):966-72. doi: 10.1097/CCM.0000000000001569.
6
Early Brain Injury and Soluble ST2 After Nontraumatic Subarachnoid Hemorrhage.非创伤性蛛网膜下腔出血后脑早期损伤与可溶性 ST2
Stroke. 2021 Aug;52(8):e494-e496. doi: 10.1161/STROKEAHA.121.035372. Epub 2021 Jun 25.
7
Early matrix metalloproteinase-9 concentration in the first 48 h after aneurysmal subarachnoid haemorrhage predicts delayed cerebral ischaemia: An observational study.动脉瘤性蛛网膜下腔出血后48小时内早期基质金属蛋白酶-9浓度可预测迟发性脑缺血:一项观察性研究。
Eur J Anaesthesiol. 2016 Sep;33(9):662-9. doi: 10.1097/EJA.0000000000000494.
8
Continuous electroencephalography predicts delayed cerebral ischemia after subarachnoid hemorrhage: A prospective study of diagnostic accuracy.连续脑电图预测蛛网膜下腔出血后迟发性脑缺血:一项诊断准确性的前瞻性研究。
Ann Neurol. 2018 May;83(5):958-969. doi: 10.1002/ana.25232. Epub 2018 May 16.
9
Serum Soluble ST2 as a Novel Inflammatory Marker in Acute Ischemic Stroke.血清可溶性ST2作为急性缺血性卒中的一种新型炎症标志物
Clin Lab. 2018 Sep 1;64(9):1349-1356. doi: 10.7754/Clin.Lab.2018.180105.
10
Temporal profile of plasma adiponectin level and delayed cerebral ischemia in patients with subarachnoid hemorrhage.蛛网膜下腔出血患者血浆脂联素水平的时间特征与迟发性脑缺血。
J Clin Neurosci. 2014 Jun;21(6):1007-10. doi: 10.1016/j.jocn.2013.10.020. Epub 2013 Dec 22.

引用本文的文献

1
Utility and rationale for continuous EEG monitoring: a primer for the general intensivist.持续脑电图监测的作用及基本原理:普通重症监护医生入门指南
Crit Care. 2024 Jul 16;28(1):244. doi: 10.1186/s13054-024-04986-0.
2
Interleukins in Epilepsy: Friend or Foe.癫痫中的细胞因子:是敌是友?
Neurosci Bull. 2024 May;40(5):635-657. doi: 10.1007/s12264-023-01170-2. Epub 2024 Jan 24.
3
Common Pathways of Epileptogenesis in Patients With Epilepsy Post-Brain Injury: Findings From a Systematic Review and Meta-analysis.脑损伤后癫痫患者致痫机制的常见途径:系统评价和荟萃分析的结果。
Neurology. 2023 Nov 27;101(22):e2243-e2256. doi: 10.1212/WNL.0000000000207749.
4
Association of Soluble ST2 With Functional Outcome, Perihematomal Edema, and Immune Response After Intraparenchymal Hemorrhage.可溶性 ST2 与脑内出血后功能结局、血肿周围水肿和免疫反应的关系。
Neurology. 2023 Mar 28;100(13):e1329-e1338. doi: 10.1212/WNL.0000000000206764. Epub 2022 Dec 22.
5
Spontaneous subarachnoid haemorrhage.自发性蛛网膜下腔出血。
Lancet. 2022 Sep 10;400(10355):846-862. doi: 10.1016/S0140-6736(22)00938-2. Epub 2022 Aug 16.
6
Biomarkers Utility: At the Borderline between Cardiology and Neurology.生物标志物的效用:处于心脏病学与神经病学的交界处
J Cardiovasc Dev Dis. 2021 Oct 25;8(11):139. doi: 10.3390/jcdd8110139.
7
Role of Interleukin-1 Receptor-Like 1 (ST2) in Cerebrovascular Disease.白细胞介素-1 受体样 1(ST2)在脑血管病中的作用。
Neurocrit Care. 2021 Dec;35(3):887-893. doi: 10.1007/s12028-021-01284-3. Epub 2021 Jul 6.
8
Therapeutic Opportunities of Interleukin-33 in the Central Nervous System.白细胞介素-33 在中枢神经系统中的治疗机会。
Front Immunol. 2021 May 17;12:654626. doi: 10.3389/fimmu.2021.654626. eCollection 2021.
9
Aneurysmal Subarachnoid Hemorrhage.颅内动脉瘤性蛛网膜下腔出血。
Neurol Clin. 2021 May;39(2):419-442. doi: 10.1016/j.ncl.2021.02.006. Epub 2021 Mar 31.
10
Challenges and Opportunities in Multimodal Monitoring and Data Analytics in Traumatic Brain Injury.创伤性脑损伤多模态监测与数据分析中的挑战与机遇
Curr Neurol Neurosci Rep. 2021 Feb 2;21(3):6. doi: 10.1007/s11910-021-01098-y.

本文引用的文献

1
Soluble ST2 links inflammation to outcome after subarachnoid hemorrhage.可溶性 ST2 与蛛网膜下腔出血后结局相关。
Ann Neurol. 2019 Sep;86(3):384-394. doi: 10.1002/ana.25545. Epub 2019 Jul 30.
2
Plasma Levels of IL-6, IL-8, IL-10, ICAM-1, VCAM-1, IFNγ, and TNFα are not Associated with Delayed Cerebral Ischemia, Cerebral Vasospasm, or Clinical Outcome in Patients with Subarachnoid Hemorrhage.血浆中 IL-6、IL-8、IL-10、ICAM-1、VCAM-1、IFNγ 和 TNFα 的水平与蛛网膜下腔出血患者的迟发性脑缺血、脑血管痉挛或临床转归无关。
World Neurosurg. 2019 Aug;128:e1131-e1136. doi: 10.1016/j.wneu.2019.05.102. Epub 2019 May 20.
3
Predictive Accuracy of Alpha-Delta Ratio on Quantitative Electroencephalography for Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage: Meta-Analysis.定量脑电图α-δ比值对动脉瘤性蛛网膜下腔出血患者迟发性脑缺血的预测准确性:Meta分析
World Neurosurg. 2019 Jun;126:e510-e516. doi: 10.1016/j.wneu.2019.02.082. Epub 2019 Feb 27.
4
Cognitive Impairment, Functional Outcome, and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage.颅内动脉瘤性蛛网膜下腔出血后的认知障碍、功能转归及迟发性脑缺血
World Neurosurg. 2019 Apr;124:e558-e562. doi: 10.1016/j.wneu.2018.12.152. Epub 2019 Jan 10.
5
Lateralized periodic discharges frequency correlates with glucose metabolism.优势半球周期性放电频率与葡萄糖代谢相关。
Neurology. 2019 Feb 12;92(7):e670-e674. doi: 10.1212/WNL.0000000000006903. Epub 2019 Jan 11.
6
Effect of epileptiform abnormality burden on neurologic outcome and antiepileptic drug management after subarachnoid hemorrhage.蛛网膜下腔出血后痫样异常负荷对神经功能结局和抗癫痫药物管理的影响。
Clin Neurophysiol. 2018 Nov;129(11):2219-2227. doi: 10.1016/j.clinph.2018.08.015. Epub 2018 Sep 1.
7
Role of C-Reactive Protein at Sites of Inflammation and Infection.C-反应蛋白在炎症和感染部位的作用。
Front Immunol. 2018 Apr 13;9:754. doi: 10.3389/fimmu.2018.00754. eCollection 2018.
8
Continuous electroencephalography predicts delayed cerebral ischemia after subarachnoid hemorrhage: A prospective study of diagnostic accuracy.连续脑电图预测蛛网膜下腔出血后迟发性脑缺血:一项诊断准确性的前瞻性研究。
Ann Neurol. 2018 May;83(5):958-969. doi: 10.1002/ana.25232. Epub 2018 May 16.
9
Early Diagnosis of Delayed Cerebral Ischemia: Possible Relevance for Inflammatory Biomarkers in Routine Clinical Practice?迟发性脑缺血的早期诊断:炎症生物标志物在常规临床实践中可能具有的相关性?
World Neurosurg. 2017 Aug;104:152-157. doi: 10.1016/j.wneu.2017.05.021. Epub 2017 May 13.
10
Epileptiform abnormalities predict delayed cerebral ischemia in subarachnoid hemorrhage.癫痫样异常可预测蛛网膜下腔出血后的迟发性脑缺血。
Clin Neurophysiol. 2017 Jun;128(6):1091-1099. doi: 10.1016/j.clinph.2017.01.016. Epub 2017 Jan 29.

可溶性 ST2 与非创伤性蛛网膜下腔出血后新的癫痫样异常有关。

Soluble ST2 Is Associated With New Epileptiform Abnormalities Following Nontraumatic Subarachnoid Hemorrhage.

机构信息

From the Department of Neurology (I.A.L., S.F.Z., M.B.W., R.L.S., T.L.-M., W.T.K., E.S.R.), Massachusetts General Hospital, Boston.

Department of Neurology, Yale School of Medicine, New Haven, CT (J.A.K).

出版信息

Stroke. 2020 Apr;51(4):1128-1134. doi: 10.1161/STROKEAHA.119.028515. Epub 2020 Mar 11.

DOI:10.1161/STROKEAHA.119.028515
PMID:32156203
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7123848/
Abstract

Background and Purpose- We evaluated the association between 2 types of predictors of delayed cerebral ischemia after nontraumatic subarachnoid hemorrhage, including biomarkers of the innate immune response and neurophysiologic changes on continuous electroencephalography. Methods- We studied subarachnoid hemorrhage patients that had at least 72 hours of continuous electroencephalography and blood samples collected within the first 5 days of symptom onset. We measured inflammatory biomarkers previously associated with delayed cerebral ischemia and functional outcome, including soluble ST2 (sST2), IL-6 (interleukin-6), and CRP (C-reactive protein). Serial plasma samples and cerebrospinal fluid sST2 levels were available in a subgroup of patients. Neurophysiologic changes were categorized into new or worsening epileptiform abnormalities (EAs) or new background deterioration. The association of biomarkers with neurophysiologic changes were evaluated using the Wilcoxon rank-sum test. Plasma and cerebrospinal fluid sST2 were further examined longitudinally using repeated measures mixed-effects models. Results- Forty-six patients met inclusion criteria. Seventeen (37%) patients developed new or worsening EAs, 21 (46%) developed new background deterioration, and 8 (17%) developed neither. Early (day, 0-5) plasma sST2 levels were higher among patients with new or worsening EAs (median 115 ng/mL [interquartile range, 73.8-197]) versus those without (74.7 ng/mL [interquartile range, 44.8-102]; =0.024). Plasma sST2 levels were similar between patients with or without new background deterioration. Repeated measures mixed-effects modeling that adjusted for admission risk factors showed that the association with new or worsening EAs remained independent for both plasma sST2 (β=0.41 [95% CI, 0.09-0.73]; =0.01) and cerebrospinal fluid sST2 (β=0.97 [95% CI, 0.14-1.8]; =0.021). IL-6 and CRP were not associated with new background deterioration or with new or worsening EAs. Conclusions- In patients admitted with subarachnoid hemorrhage, sST2 level was associated with new or worsening EAs but not new background deterioration. This association may identify a link between a specific innate immune response pathway and continuous electroencephalography abnormalities in the pathogenesis of secondary brain injury after subarachnoid hemorrhage.

摘要

背景与目的-我们评估了 2 种非创伤性蛛网膜下腔出血后迟发性脑缺血的预测因子之间的关联,包括固有免疫反应的生物标志物和连续脑电图上的神经生理变化。方法-我们研究了至少有 72 小时连续脑电图和在症状发作的前 5 天内采集的血液样本的蛛网膜下腔出血患者。我们测量了先前与迟发性脑缺血和功能结局相关的炎症生物标志物,包括可溶性 ST2(sST2)、白细胞介素-6(IL-6)和 C 反应蛋白(CRP)。在亚组患者中可获得连续的血浆样本和脑脊液 sST2 水平。神经生理变化分为新出现或恶化的癫痫样异常(EAs)或新出现的背景恶化。使用 Wilcoxon 秩和检验评估生物标志物与神经生理变化之间的关联。使用重复测量混合效应模型进一步纵向检查血浆和脑脊液 sST2。结果-46 名患者符合纳入标准。17 名(37%)患者出现新出现或恶化的 EAs,21 名(46%)患者出现新出现的背景恶化,8 名(17%)患者未出现。新出现或恶化的 EAs 患者的早期(第 0-5 天)血浆 sST2 水平较高(中位数 115ng/mL[四分位距,73.8-197]),而无 EAs 患者的血浆 sST2 水平较低(74.7ng/mL[四分位距,44.8-102];=0.024)。新出现背景恶化患者的血浆 sST2 水平与无新出现背景恶化患者的血浆 sST2 水平相似。在调整入院危险因素后,重复测量混合效应模型显示,新出现或恶化的 EAs 与血浆 sST2(β=0.41[95%CI,0.09-0.73];=0.01)和脑脊液 sST2(β=0.97[95%CI,0.14-1.8];=0.021)均存在独立关联。IL-6 和 CRP 与新出现的背景恶化或新出现或恶化的 EAs 均无关联。结论-在因蛛网膜下腔出血而入院的患者中,sST2 水平与新出现或恶化的 EAs 相关,但与新出现的背景恶化无关。这种关联可能表明特定的固有免疫反应途径与蛛网膜下腔出血后继发性脑损伤的连续脑电图异常之间存在联系。